AI tool helps doctors diagnose and treat cancer

CareIntelligence for Oncology, as the app is called, will help oncologists quickly grasp a patient’s history and disease progression by displaying essential data. GE said it wants to save doctors time in processing paperwork so they can focus on patient care.

GE HealthCare has just announced a new artificial intelligence application that helps doctors save time diagnosing and treating cancer.

According to a Deloitte report, healthcare data is difficult to analyze, and up to 97% of data in hospitals is not processed by technology. That information is stored on devices from multiple vendors and in file formats such as images, test results, clinical notes, and metrics, leaving doctors with a lot of sorting to do.

“This is very time consuming, very frustrating for physicians,” Dr. Taha Kass-Hout, global chief science and technology officer at GE HealthCare, told CNBC in an interview.

The CareIntelligence for Oncology app can summarize clinical data and identify when patients are off-course. It alerts patients when they miss tests, so doctors can determine the best next steps for treatment.

“For cancer patients, the treatment journey can span years and involve many visits,” says Kass-Hout.

CareIntelligence for Oncology can also help identify relevant clinical tests that a patient is eligible for, saving oncologists hours of work, said Chelsea Vane, vice president of digital products at GE HealthCare. That process previously required doctors to search databases, memorize parameters, make exclusions, and pore over patient records to determine the appropriate treatment plan. “What we’re doing is eliminating that,” Vane said.

The CareIntelligence for Oncology application provides powerful support for doctors in treating cancer.

The app's goal is to save time and effort for oncologists, but if a doctor wants to go into more detail, CareIntelligence for Oncology allows them to view the referenced original record.

GE HealthCare plans to make CareIntelligence for Oncology widely available to U.S. customers in 2025, and it will initially be optimized for prostate and breast cancer. Healthcare organizations like Tampa General Hospital are evaluating the app’s effectiveness. Since the tool is cloud-based, it will drive recurring revenue for GE HealthCare.

GE HealthCare also plans to introduce more apps under the CareIntelligence brand in the future, Kass-Hout said. The cancer treatment tool and healthcare organizations will be able to easily select the apps they want to enable.

GE HealthCare also hopes to integrate CareIntelligence products with several other early-stage AI initiatives the company unveiled on Monday.

The healthcare conglomerate highlighted five new AI products it is developing, including a collaborative team of AI agents, a tool to predict the recurrence of a type of breast cancer, and a tool to alert on suspicious ultrasounds.

(According to CNBC)

Source: https://www.baogiaothong.vn/cong-cu-ai-giup-bac-si-chan-doan-va-dieu-tri-ung-thu-192241022010600282.htm